Lv2
126 积分 2023-12-21 加入
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
18天前
已完结
Prediction of pharmacokinetic parameters of inhaled indacaterol formulation in healthy volunteers using physiologically-based pharmacokinetic (PBPK) model
1个月前
已完结
Systematic Review and Meta‐Analysis of the Efficacy and Risk of Adverse Events of Dupilumab in the Treatment of Prurigo Nodularis
1个月前
已完结
Basal and Histalog-Stimulated Gastric Secretion in Control Subjects and in Patients with Peptic Ulcer or Gastric Cancer
1个月前
已完结
Time-dependent population PK models of single-agent atezolizumab in patients with cancer
3个月前
已完结
Time-dependent population PK models of single-agent atezolizumab in patients with cancer
3个月前
已完结
Confirmatory analysis for phase III population pharmacokinetics
3个月前
已完结
Once‐Daily Inhaled Budesonide for the Treatment of Asthma: Clinical Evidence and Pharmacokinetic Explanation
4个月前
已完结
Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects
4个月前
已完结
Safety, Tolerability, and Pharmacokinetics of a New Formulation of Nemiralisib Administered via a Dry Powder Inhaler to Healthy Individuals
4个月前
已完结
皖公网安备34019202002308
